苏智祥, 邓智平, 孙海凤, 赵征. 康艾注射液辅助治疗乳腺癌的疗效和安全性分析[J]. 蚌埠医科大学学报, 2016, 41(10): 1288-1289,1292. DOI: 10.13898/j.cnki.issn.1000-2200.2016.10.009
    引用本文: 苏智祥, 邓智平, 孙海凤, 赵征. 康艾注射液辅助治疗乳腺癌的疗效和安全性分析[J]. 蚌埠医科大学学报, 2016, 41(10): 1288-1289,1292. DOI: 10.13898/j.cnki.issn.1000-2200.2016.10.009
    SU Zhi-xiang, DENG Zhi-ping, SUN Hai-feng, ZHAO Zheng. The efficacy and safety analysis of Kang'ai injection in the treatment of breast cancer[J]. Journal of Bengbu Medical University, 2016, 41(10): 1288-1289,1292. DOI: 10.13898/j.cnki.issn.1000-2200.2016.10.009
    Citation: SU Zhi-xiang, DENG Zhi-ping, SUN Hai-feng, ZHAO Zheng. The efficacy and safety analysis of Kang'ai injection in the treatment of breast cancer[J]. Journal of Bengbu Medical University, 2016, 41(10): 1288-1289,1292. DOI: 10.13898/j.cnki.issn.1000-2200.2016.10.009

    康艾注射液辅助治疗乳腺癌的疗效和安全性分析

    The efficacy and safety analysis of Kang'ai injection in the treatment of breast cancer

    • 摘要: 目的:对比和分析乳腺癌患者在常规化疗方案的基础上加用康艾注射液的价值及不良反应情况,进一步提高乳腺癌患者的临床治疗效果。方法:将106例乳腺癌患者按照随机双盲对照的原则分为观察组和对照组,各53例,入组患者术后均常规给予CTF方案(环磷酰胺+吡柔吡星+氟尿嘧啶)化疗,观察组在化疗的基础上同时加用康艾注射液,观察2组患者总有效率和不良反应发生率。结果:2组患者的治疗总有效率差异无统计学意义(P>0.05);观察组患者的各种不良反应发生率均低于对照组(P<0.05~P<0.01)。结论:对于乳腺癌术后的患者在给予CTF方案化疗的基础上加以康艾注射液,能够明显减轻患者化疗期间药物的不良反应,减少患者的痛苦,值得推荐。

       

      Abstract: Objective: To further improve the clinical effects of patients with breast cancer,and compare and analyze the value and side reaction of Kang'ai injection based on conventional chemotherapy.Methods: One hundred and six patients with breast cancer were randomly divided into the observation group and control group according to the randomized double-blind controlled principle(53 cases each group).All patients were treated with the routine CTF scheme(cyclophosphamide,pirarubicin and fluorouracil)chemotherapy,the observation group were additionally treated with Kang'ai injection.The total effective rate and incidence rate of adverse reaction between two groups were compared.Results: The difference of the total effective rate of treatment between two groups was not statistically significant(P>0.05).Compared with the control group,the incidence of adverse reactiyon in observation group significantly decreased,the difference of which was statistically significant(P<0.05-P<0.01).Conclusions: The treatment of the postoperative patients with breast cancer with Kang'ai injection based on the CTF chemotherapy can significantly reduce the adverse reaction and pain,which is worth of recommendation.

       

    /

    返回文章
    返回